2004D-0524 - Draft Guidance for Industry: ANDAs: Pharmaceutical Solid Polymorphism; Availability
FDA Comment Number : EC1
Submitter : Mr. Shashank Upadhye Date & Time: 03/03/2005 04:03:58
Organization : Eon Labs, Inc.
Drug Industry
Category :
Issue Areas/Comments
GENERAL
GENERAL
See Attachment